Published online Nov 6, 2021. doi: 10.12998/wjcc.v9.i31.9431
Peer-review started: March 26, 2021
First decision: April 28, 2021
Revised: May 6, 2021
Accepted: September 27, 2021
Article in press: September 27, 2021
Published online: November 6, 2021
Processing time: 216 Days and 22.1 Hours
Atrophic gastritis is a precancerous lesion of the stomach. It has been reported that pepsinogen (PG) can reflect the morphology and function of the gastric mucosa, and it is therefore used as a marker for the early diagnosis of atrophic gastritis.
To evaluate the diagnostic value of serum PG for degree of gastric mucosal atrophy in asymptomatic Chinese upon physical examination.
Medical data were collected from subjects who underwent transnasal gastroscopy between October 2016 and October 2018. For each study subject, serum PG levels and presence of Helicobacter pylori (H. pylori) infection were investigated. Pathology was evaluated using the Operative Link for Gastritis Assessment (OLGA) classification and Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM) systems. All statistical analyses were carried out using SPSS statistical software.
A total of 2256 subjects were enrolled and 1922 cases were finally included in the study. Based on the OLGA grading system, the levels of PGI were slightly decreased, while those of PGII were slightly increased. The PGI/PGII ratio (PGR) was reduced with increasing atrophy. The association between PG and OLGA grading was higher compared with that between PG and the OLGIM grading system. Compared with the OLGA-0 group, a statistically significant difference was observed in the mean age of OLGA-I, III, and IV groups (P < 0.05). In the H. pylori-positive subjects, the PGR levels were notably lower in the OLGA-I, II, and III groups compared with the OLGA-0 group (P < 0.05). H. pylori-positive subjects exhibited significantly higher PGI and PGII serum levels and a significantly lower PGR compared with H. pylori-negative patients in different OLGA groups (P < 0.05).
Serum PG levels may represent a non-invasive screening marker for gastric mucosal atrophy in asymptomatic subjects.
Core Tip: The current study evaluated the diagnostic value of serum pepsinogen (PG) as a screening marker for atrophic gastritis in asymptomatic healthy check-up populations in different regions of China. Serum PG levels were closely associated with Operative Link for Gastritis Assessment grading and could be used as an effective non-invasive screening tool for atrophic gastritis in asymptomatic subjects. In addition, better results could be obtained in Helicobacter pylori-positive individuals. Screening is more necessary in the elderly, and the application of the aforementioned screening tool may be beneficial for this population.